Nina Wronkowitz

发表

Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome

J. Kaufman, P. Arner, D. Lamers, 2011, Diabetes.

LAPSInsulin115: A novel ultra‐long‐acting basal insulin with a unique action profile

J. Eckel, Nina Wronkowitz, S. Görgens, 2017, Diabetes, obesity & metabolism.

Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function

N. Tennagels, J. Eckel, Nina Wronkowitz, 2016, Cardiovascular Diabetology.

Adipose tissue dysfunction and inflammation in cardiovascular disease.

Nina Wronkowitz, H. Sell, J. Eckel, 2014, Frontiers of hormone research.

Soluble dipeptidyl peptidase-4 induces microvascular endothelial dysfunction through proteinase-activated receptor-2 and thromboxane A2 release

Nina Wronkowitz, H. Sell, J. Eckel, 2016, Journal of hypertension.

DPP4 in Diabetes

Nina Wronkowitz, J. Eckel, D. Röhrborn, 2015, Front. Immunol..

Adipocyte-derived factors impair insulin signaling in differentiated human vascular smooth muscle cells via the upregulation of miR-143.

Nina Wronkowitz, D. Ouwens, H. Sell, 2014, Biochimica et biophysica acta.

Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2.

J. Eckel, Nina Wronkowitz, H. Sell, 2014, Biochimica et biophysica acta.

Soluble dipeptidyl peptidase-4 induces microvascular endothelial dysfunction through proteinase-activated receptor-2 and thromboxane A2 release

Nina Wronkowitz, H. Sell, J. Eckel, 2016, Journal of hypertension.